Literature DB >> 7721246

OK-432 chemical pleurodesis for the treatment of persistent chylothorax.

A Nakano1, M Kato, T Watanabe, N Kawai, H Ota, T Hattori, Y Kobayashi, Y Nimura.   

Abstract

A 52-year-old woman with thoracic esophageal carcinoma was admitted to our hospital. Standard radical esophagectomy was carried out via a right posterolateral thoracotomy and laparotomy. A drainage tube was removed from the right side of the chest on the 9th postoperative day. Three days later a chest roentgenogram showed massive left pleural effusion, and a tube was inserted into the left pleural cavity. The volume of the effusion was 900 ml/day and chylothorax was diagnosed. Conservative therapy was applied for 30 days, but chyle leakage persisted. Intra-pleural infusion of OK-432, a Su-strain of Streptococcus pyogenes, and doxycycline hydrochloride was carried out to seal the leakage point. The effusion stopped immediately after the procedure. There were no major side effects. This procedure should be considered the treatment of choice for patients with persistent chylothorax not responding to initial conservative management.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7721246

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Octreotide for treating chylothorax after cardiac surgery.

Authors:  Dalokay Kilic; Ekber Sahin; Oner Gulcan; Bulent Bolat; Riza Turkoz; Ahmet Hatipoglu
Journal:  Tex Heart Inst J       Date:  2005

2.  Bilateral chylothorax after transsternal total thymectomy: resolution with short period of fasting and total parenteral nutrition.

Authors:  Jinsik Kim; Jee Won Chang; Su Wan Kim; Seogjae Lee
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

3.  Treatment of Chylothorax complicating pulmonary resection with hypertonic glucose Pleurodesis.

Authors:  Kejian Zhang; Changyuan Li; Mingrui Zhang; Yang Li
Journal:  J Cardiothorac Surg       Date:  2021-05-28       Impact factor: 1.637

4.  Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study.

Authors:  Bruce Sabath; Hasan A Muhammad; Amulya Balagani; David E Ost; Erik Vakil; Tahreem Ahmed; Macarena R Vial; Horiana B Grosu
Journal:  BMC Cancer       Date:  2018-10-01       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.